Hybrid OR

May 12, 2021

Innovation and entrepreneurship, collaboration and strong commitment to ESG goals power Philips’ continued relevance to society as it reaches its 130th anniversary

Estimated reading time: 7-9 minutes

On May 15, 2021, Royal Philips marks 130 years of innovation, collaboration and social responsibility. During its long history the company has continuously reinvented itself to remain societally relevant, culminating in its position today as a leading health technology company whose purpose is to improve the lives of 2.5 billion people a year by 2030 through meaningful innovation. Today, the company continues to team up with innovators, experts and society to help create new ground-breaking solutions to today’s healthcare challenges.

Innovation and entrepreneurship


Philips’ innovations span the health continuum from healthy living and disease prevention to diagnosis, treatment and care in the home, bringing together devices, systems, software, artificial intelligence (AI) and advanced analytics to develop intelligent solutions that help consumers live healthy lifestyles and support healthcare providers to deliver on the quadruple aim: enhancing the patient experience, improving health outcomes, lowering the cost of care, and improving the work life of care providers. Philips has four innovation hubs and multiple innovation and manufacturing sites. Philips spends EUR 1.8 billion annually on R&D to fuel the company’s growth and intellectual property, which comprises approx. 59,000 patent rights and 31,000 trademarks.

Personalization of consumer health: AI is driving the personalization of consumer health enabling a new generation of solutions that adapt to people’s unique behaviour and needs. Philips recently introduced its AI-powered Sonicare Power Toothbrush 9900 Series Prestige with SenseIQ technology that senses, adapts and cares. Philips Teledentistry offers users the possibility to virtually connect with dental professionals, following a recent treatment and to get reassurance. Partnering with health insurers, Philips focuses on preventative oral care. Another example is Philips’ advanced Shaver Series 9000 with SkinIQ technology that is currently being rolled out globally, which continuously adapt to people’s personal behaviour and needs giving personalized skin comfort and superior closeness even on a five-day beard [1].

philips shavers

Precision diagnosis: Philips’ AI Workflow Suite – IntelliSpace – a solution for AI-assisted radiology workflows, automatically distributing data to AI applications to increase efficiency/productivity, reduce staff overload, and enhance the patient experience. It seamlessly works together with Philips diagnostic imaging, such as Philips MR and CT solutions, and informatics solutions, such as its image IntelliSpace Portal 12, an AI-based automated and connected advanced visualization and image analysis solution. It also integrates into existing radiology department and hospital infrastructures, either on-premise or in a private cloud environment, it automatically orchestrates the routing of clinical data to the appropriate AI application to allow data analysis without user interaction, and displays the results.

Minimally-invasive treatment: With Philips Image Guided Therapy System – Azurion –, the company is helping to transform treatment for a wide range of diseases, including cardiovascular disease, from open surgery that required weeks of hospitalization to minimally-invasive procedures where patients can go home the next day or sometimes even on the same day as the procedure. Azurion integrates control of imaging, hemodynamic, informatics and physiology applications, including Philips’ portfolio of catheters and pressure wires that can produce ultrasound images of the interior of blood vessels and perform blood pressure measurements. There is a growing body of clinical evidence that the use of such technologies in conjunction with interventional X-ray improves patient outcomes. Philips’ transformative ClarifEye surgical navigation software adds 3D augmented reality (AR) to provide live intra-operative visualization of internal anatomies to guide and inform delicate minimally-invasive spine interventions.

philips eicu telemedicine program

Telehealth: Philips pioneered remote patient monitoring telehealth with its eICU (electronic Intensive Care Unit) telemedicine program. As part of this program, it helped Emory Healthcare (Atlanta, U.S) to establish the first-of-its-kind remote intercontinental intensive care unit monitoring system, allowing U.S. critical care specialists stationed in Sydney (Australia) working during the daytime to monitor patients in the Atlanta ICU overnight, helping to reduce the burden of traditional night shift work. An independent audit showed that the program saved an estimated $4.5 million over a 15-month period.

In the fight against COVID-19, Philips developed a variety of wirelessly connected solutions to safely monitor patients remotely, such as Philips Wearable Biosensor – Healthdot – [2], allowing health care professionals to remotely monitor patients in hospital, but especially out-of-hospital and during transitional care. Another example is Philips Fetal and Maternal Pod and Patch – Avalon CL –, allow for continuous, non-invasive monitoring of pregnant women and their unborn babies in the hospital and in the comfort of the home. Philips pre-hospital wireless monitoring solution for emergency medical response - Tempus ALS -, delivers real-time bidirectional data transfer for remote patient monitoring, giving EMS responders a new approach to pre-hospital care.

philips fetal and maternal pod and patch



In an ever more complex and interconnected world, Philips has always believed that meaningful innovation in healthcare involves partnerships and collaborations with leading clinical researchers and care providers. Examples of these partnerships include:

University Medical Center Utrecht (The Netherlands): Together with Philips, University Medical Center Utrecht is advancing precision diagnosis through breakthrough quantitative MRI technology - MR-STAT - initially developed by University Medical Center Utrecht. The technology is a paradigm shift in MR, relying on a new smart acquisition scheme and machine-assisted reconstruction. It delivers multiple quantitative MR parameters in a single fast scan, and represents a significant advance in MR tissue classification, fuelling big data algorithms and AI-enabled integrated diagnostic solutions. Together, Philips and University Medical Center Utrecht will establish a global clinical research network with the aim of fully commercializing the technology.

Dana-Farber Cancer Institute (Boston, U.S.): Co-development of Philips Oncology Pathways powered by Dana-Farber to provide clinicians worldwide with access to best-practice, personalized care regimens recommendations for patients based on the latest scientific advances. Based on an individual patient’s data, clinicians can navigate through the pathway options to make clinical decisions and provide personalized treatment recommendations, including clinical trial participation.

Singapore General Hospital (Singapore): As part of a collaboration with Singapore General Hospital’s Digital and Computational Pathology Center of Excellence, Philips Pathology Suite – IntelliSite – is being used in the development of digital pathology capabilities and AI-based tools for primary diagnosis, training, and R&D.

The United States Department of Veterans Affairs (VA): VA is the largest integrated healthcare system in the U.S., consisting of more than 1,700 sites and serving nearly nine million veterans each year. It has become a leader in developing telehealth services to improve access to care and federate care delivery. Philips is helping the VA to drive its overall telehealth program. Together, the two organizations are creating the world’s largest tele-critical-care system, providing veterans with remote access to intensive care expertise, regardless of their location, via a centralized Philips eICU. Philips is also realizing Virtual Care Stations in remote areas across the U.S., enabling access to high-quality care for all VA veteran members.

MONET Technologies Inc. (Japan) - Philips, MONET Technologies and Ina City are addressing the rapidly aging population and shortage of medical facilities and healthcare professionals in Japan through a mobile healthcare vehicle concept equipped with connected care technologies. Supporting people that are elderly or frail, a caregiver boards a mobile healthcare vehicle to visit a patient’s home and offer at-home examinations while a doctor at a remote location gives medical consultations via video. We are currently testing this concept with one mobile vehicle.

Long-term Strategic Partnership


Philips enters into long-term strategic partnerships with hospitals and hospital groups to give them continuous managed-service access to the latest technology innovations, pioneering revolutionary new business models.

Klinikum Stuttgart (Stuttgart, Germany): A recent Philips agreement with Klinikum Stuttgart hospital covers state-of-the-art diagnostic imaging and intelligent informatics solutions, together with joint development of new workflows and connected care solutions to improve the quality and cost-effectiveness of patient care, as well as the patients and staff experience.

Flevo Hospital (Almere, The Netherlands): A 10-year strategic partnership agreement to realize four strategic objectives - the ‘right care in the right place' through innovation and the optimal use of technology; modernizing the hospital’s care and strengthening communication with patients and partners; increasing employee motivation and satisfaction; and cost saving and efficiency improvement for medical technology.

Social responsibility


Philips’ recognition of its social responsibility goes back to its early years, when in 1932 it began screening its staff, then their families, and eventually the entire population of Eindhoven (the city where the company was founded), for tuberculosis (TB), reducing TB rates to less than half that in other large Dutch cities. With no effective antimicrobials available to combat TB, its recommended treatment regimen was rest, a healthy diet, exercise and fresh air – lifestyle interventions that are reflected in the company’s current personal health solutions. In the 1990s Philips also helped to pioneer a national breast cancer screening program in the Netherlands.

Today, the company’s Environmental, Social and Corporate Governance (ESG) commitments are enshrined in its new 5-year ESG targets and strategic plans. Philips is already carbon neutral in its operations and is set to further reduce its CO2 emissions in line with 1.5°C global warming and source 75% of its total energy consumption from renewables. The company also aims to increase revenue from circular economy solutions to 25% of sales by 2025. As part of its 2025 target to improve the lives of 2 billion people a year, Philips is committed to improving access to care for 300 million people in underserved communities. In collaboration with key strategic partners and the Philips Foundation, it is enabling care in resource constrained settings, for example, by putting portable ultrasound solutions into the hands of trained midwives at primary care facilities in Kenya, and establishing hospital-based cardiology centers in regional cities across India.

[1] Versus predecessor Philips Series S9000
[2] Currently available in the Netherlands only

Share on social media

  • Link copied



Joost Maltha

Joost Maltha

Philips Global Press Office

Tel: +31 6 10 55 8116

You are about to visit a Philips global content page


You are about to visit the Philips USA website.

I understand

You are about to visit a Philips global content page


You are about to visit the Philips USA website.

I understand

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.